Anti-inflammatory therapy reduces wheezing after bronchiolitis

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 5, 1996, Pages 512-517

  Reijonen, Tiina ^a   Korppi, Matti ^a   Kuikka, Liisa ^a   Remes, Kyllikki ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; BUDESONIDE; CROMOGLYCATE DISODIUM;

ARTICLE; ATOPY; BRONCHIOLITIS; BRONCHUS OBSTRUCTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DYSPNEA; FACE MASK; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WHEEZING;

EID: 0029988475     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170300066013     Document Type: Article

References (34)

1. Welliver JR. Welliver C. Bronchiolitis. Pediatr Rev. 1993;14:134-139.
2. Phelan PD, Landau LI, Olinsky A, eds. Respiratory Illness in Childhood. 3rd ed. Boston, Mass: Blackwell Scientific Publications Inc; 1982:76-84.
3. Henry RL, Hodges IGC, Milner AD, Stokes GM. Respiratory problems 2 years after acute bronchiolitis in infancy. Arch Dis Child. 1983;58:713-716
4. Korppi M, Reijonen T, Pöysä L, Juntunen-Backman K. A 2-year to 3-year out-come after bronchiolitis. AJDC. 1993;147:628-631.
5. Korppi M, Kuikka L, Reijonen T, Remes K, Juntunen-Backman K, Launialala K. Bronchial asthma and hyperreactivity after early childhood bronchiolitis and pneumonia: an 8-year follow-up study. Arch Pediatr Adolesc Med. 1994;148:1079-1084.
6. Price J. Acute and long-term effects of viral bronchiolitis in infancy. Lung. 1990; 167(suppl):414-422.
7. Pullan C, Hey E, Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. BMJ. 1982;284:1665-1669.
8. Mok J, Simpson H. Outcome for acute bronchiolitis, bronchiolitis and pneumonia in infancy. Arch Dis Child. 1984;59:306-309.
9. Busse WW. Infections. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma: Basic Mechanisms and Clinical Management. Orlando, Fla: Academic Press Inc; 1988:483-499.
10. Cogswell J. Bronchiolitis: long-term sequelae. Paediatr Respir Med. 1993;1:9-11.
11. Rachelefsky GS, Warner JO. International consensus on the management of pediatric asthma: a summary statement. Pediatr Pulmonol. 1993;15:125-127.
12. Carlsen KH, Leegaard J, Larsen S, Orstavik I. Nebulized beclomethasone dipropionate in recurrent obstructive episodes after bronchiolitis. Arch Dis Child. 1988;63:1428-1433.
13. Maayan C, Itzhaki T, Bar-Yishay E, Gross S, Tal A, Godfrey S. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr Pulmonol. 1986;2:9-14.
14. Reijonen T, Korppi M, Pitkäkangas S, Tenhola S, Remes K. The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med. 1995;149:686-692.
15. Saarinen UM, Juntunen K, Kajosaari M, Björksten F. Serum immunoglobulin E in atopic and non-atopic children aged 6 months to 5 years. Acta Pediatr. 1982; 71:489-494.
16. Altman DG. Sample size. In: Altman DG, ed. Practical Statistics for Medical Research. London, England: Chapman & Hall Ltd; 1991:457-460.
17. Zar JH. Biostatistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall International Inc; 1984:402-403.
18. Embey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976;113:131-139.
19. Furaro S, Spier S, Drblik SP, Turgeon JP, Robert M. Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child. 1994;71:331-334.
20. Noble V, Ruggins NR, Everard MN, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child. 1992;67:285-288.
21. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet. 1990; 336:649-651.
22. Van Bever HP, Schuddinck L, Wojciechowski M, Stevens WJ. Aerosolized budesonide in asthmatic infants: a double-blind study. Pediatr Pulmonol. 1990;9:177-180.
23. Berthelsen A, Andersen JB, Busch P, et al. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. Allergy. 1986;41:266-270.
24. Geller-Bernstein C, Levin S. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration. 1982;43:294-298.
25. McCarthy TP. Nebulized budesonide in severe infantile asthma. Lancet. 1989; 1:379-380.
26. Godfrey S, Avital A, Rosler A, Mandelberg A, Uwyyed K. Nebulised budesonide in severe infantile asthma. Lancet. 1987;2:851-852.
27. Larsen GL. Asthma in children. N Engl J Med. 1992;326:1540-1545.
28. Szefler SJ. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol. 1991;88:147-165.
29. Brunette MG, Lands L, Thibodeau L-P. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics. 1988;81:624-629.
30. Hoag JE, McFadden ER Jr. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy. 1991;66:53-63.
31. Kay AB, Walsh GM, Moqbel R, et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol. 1987;80:1-8.
32. Dennis JH. A viable system for aerosol delivery in the 3rd world: jet nebulisers powered by a foot pump, Eur Respir J. 1994;7:447. Abstract.
33. Martinez FD, Wright AL, Lynn M, et al. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133-137.
34. Young S, O'Keeffe PT, Arnott J, Landau LI. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child. 1995;72:16-24.